FDA Approves first new drug SLE
Email Sign Up
Give
Menu
Menu
En Español
Search Our Site
Home
Who We Are
About Us
Our Vision
Our History
Our Commitment to DE&I
Financials
Leadership and Partners
Board of Directors
Research Committee of the Board
SAB
Leadership and Partners
Executive Staff
Young Leaders Board
The Complexity of Lupus
Why Is Lupus So Complex?
About Lupus
Symptoms
Diagnosis
Treatment
Educational Resources
Our Research
Revolutionizing Research
Research Road Map
Research We Fund
Our Progress
Get Involved in Research
Lupus Therapeutics, LLC
For Researchers
Funding Opportunities
Funded Research
Research Partners
Scientific Resources
Research Contacts
LRA Reviewers 2021 - 2022
News and Events
News
Research and Clinical Trial News
Grant Updates
Learn From Lupus — COVID-19
Press Releases
Events
For Media
Get Involved
Give
Online Donation
Other Ways to Give
Research
Find a Clinical Trial
Give to the Lupus Brain Bank
Events
Join Our Events
Walk
Host an Event
Volunteer
Educate Your Community
Advocate
Advocate
Results
Advocacy News
Community
Community Forum
Community Blog
Lupus Stories
Contact
Home
Acerca del Lupus
¿Qué es el lupus?
Síntomas comunes del lupus
Diagnóstico y tratamiento
Diagnóstico
Prueba de ANA
Tratamiento
Donate
Sign up for Updates
FDA Approves first new drug SLE
Related Posts
Lupus Research Alliance Unites the U.S. Food & Drug Administration (FDA) & Lupus Community to Launch Novel Public-Private Partnership
READ MORE
Rinvoq Advances to Phase 3 in Lupus
READ MORE
Consider Donating Your Brain to Lupus Research
READ MORE
Post navigation
Lupus Research Alliance Applauds U.S. FDA Approval of AstraZeneca’s anifrolumab-fnia (Saphnelo™) for Systemic Lupus Erythematosus (SLE)
Learn and connect with our community!
Help Us Find a Cure
For Lupus Research
Search Our Site
X
